Press Release: Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2021
Press Release: Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2021
Press Release: Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2021
新聞稿：Ascount Surgical，Inc.計劃於2021年5月11日召開第一季度財務和經營業績電話會議
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2021
Ascount Surgical，Inc.計劃於2021年5月11日召開第一季度財務和經營業績電話會議
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--April 29, 2021--
北卡羅來納州研究三角公園--(美國商業新聞網)--2021年4月29日--
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery(TM), announced today that it plans to release 2021 first quarter financial and operating results after the market closes on Tuesday, May 11, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be concurrently webcast.
亞洲網加利福尼亞州聖何塞5月11日電醫療設備公司Ascount Surgical，Inc.(紐約證券交易所美國證券交易所代碼：ASXC)正在將外科醫生和患者之間的界面數字化，以開創績效導向手術(TM)的新時代。該公司今天宣佈，計劃在2021年5月11日(星期二)市場收盤後公佈2021年第一季度財務和經營業績。該公司將於下午4：30開始召開電話會議，討論這些結果。美國東部時間同一天。電話會議將同時進行網絡直播。
To listen to the conference call on your telephone, please dial 1-855-327-6837 for domestic callers and 1-631-891-4304 for international callers, and reference conference ID 10014229 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link https://ir.asensus.com/events-and-presentations. The replay will be available on the Company's website.
要在您的電話上收聽電話會議，請撥打國內電話號碼為1-855-327-6837，國際電話號碼為1-631-891-4304，並在會議開始前大約10分鐘撥打會議ID 10014229。要訪問現場音頻網絡廣播或存檔錄音，請使用以下鏈接https://ir.asensus.com/events-and-presentations.重播將在公司網站上播出。
About Asensus Surgical, Inc.
關於Ascount Surgical，Inc.
Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the clinical intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance(R) Surgical System powered by the Intelligent Surgical Unit(TM) (ISU(TM)) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.
Ascount Surgical公司正在將外科醫生和患者之間的接口數字化，通過釋放臨牀智能來開創性能導向外科手術的新時代，從而實現始終如一的卓越結果和新的手術標準。這建立在數字腹腔鏡技術和由智能外科單元(商標)(ISU(商標))驅動的SEnhance(R)外科系統的基礎上，以加強外科醫生的控制並減少手術的可變性。通過在整個手術體驗中添加機器視覺、增強智能和深度學習功能，我們打算從整體上解決當前推動手術結果和基於價值的醫療保健的臨牀、認知和經濟缺陷。欲瞭解有關SEnhance外科系統的性能引導手術和數字腹腔鏡檢查的更多信息，請訪問網站：www.senhance.com。現已在美國、歐盟、日本、俄羅斯和部分其他國家銷售。有關使用適應症的完整清單，請訪問www.senhance.com/Indications。欲瞭解更多信息，請訪問www.asensus.com。
View source version on businesswire.com: https://www.businesswire.com/news/home/20210429005152/en/
在business wire.com上查看源代碼版本：https://www.businesswire.com/news/home/20210429005152/en/
CONTACT: INVESTOR CONTACT:
聯繫人：投資者聯繫人：
Mark Klausner or Mike Vallie, 443-213-0499
馬克·克勞斯納(Mark Klausner)或邁克·瓦利(Mike Vallie)，443-213-0499
invest@asensus.com
郵箱：Invest@asensus.com
or
或
MEDIA CONTACT:
媒體聯繫人：
Kristin Schaeffer
克里斯汀·謝弗(Kristin Schaeffer)
CG Life
CG生活
kschaeffer@cglife.com
郵箱：kschaeffer@cglif.com
(END) Dow Jones Newswires
(完)道瓊通訊社
April 29, 2021 06:55 ET (10:55 GMT)
2021年4月29日東部時間06：55(格林尼治標準時間10：55)
譯文內容由第三人軟體翻譯。